RYMGX Mutual Fund
RYMGX Mutual Fund
RYMGX Mutual Fund
S&P MidCap 400 Pure Growth Fund Class A
RYMGX Mutual Fund Overview
RYMGX Mutual Fund (S&P MidCap 400 Pure Growth Fund Class A) is managed by Guggenheim Investments with $6.8M in net assets. RYMGX expense ratio is 1.54%, holding 102 positions across sectors including Information Technology, Health Care, Industrials. Inception date: 2004-09-01.
RYMGX performance shows a YTD return of 5.00%. The 1-year return is 8.56% and the 5-year return is 2.63%.
RYMGX top holdings include Halozyme Therapeutics Inc (2.6%), Arrowhead Pharmaceuticals Inc (2.4%), Technipfmc Plc Ordinary Shares (2.3%), Carpenter Technology Corp (2.0%), Interdigital Inc (1.9%). Go to all RYMGX holdings, RYMGX sectors, or RYMGX dividends.
RYMGX can be compared against other funds. Use RYMGX overlap to find shared positions, or RYMGX vs another fund for a side-by-side view. RYMGX alternatives are available via the screener, along with tax-loss harvesting opportunities.